has a broad product portfolio that modulates the immune system. Their research focuses on developing and commercializing novel vaccines and antibody-based therapies that prevent and treat infectious, autoimmune and addictive diseases, such as Staphyl...Show all
Company (Alive / Active)
Phone: 301-770-3099
12276 Wilkins Avenue
Rockville, 20852
Maryland, United States
Total Funding | Date of Last Funding | |
---|---|---|
Nabi Biopharmaceuticals | $33.5M | Jul 4, 2003 |
See all 15 competitors |
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Smoking cessation kit and method | Jun 09, 2009 | Jul 31, 2012 | Patent |
Hapten-carrier conjugates for treating and preventing nicotine addiction | Jul 14, 2010 | Sep 27, 2011 | Patent |
Hapten-carrier conjugates for treating and preventing nicotine addiction | Jul 20, 2007 | Aug 17, 2010 | Patent |
Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women | Feb 26, 2007 | Jun 16, 2009 | Patent |
Untitled | Dec 20, 2004 | May 12, 2009 | Patent |